Untitled

Introduction

In an age where wellness trends are ever-evolving, cryotherapy has emerged as a strikingly unique approach to health and vitality. This innovative technique involves exposing the body to frigid temperatures to unlock a range of health benefits. In this comprehensive blog, we'll dive deep into the world of cryotherapy, unraveling key insights about its growth and impact on the health and wellness market. From its historical origins to current trends and practical applications, this article will provide valuable insights into the chilly world of cryotherapy.

The Historical Foundations of Cryotherapy

To truly comprehend the present-day surge of the cryotherapy market, it's essential to delve into the roots of this technique. Cryotherapy, also known as "cold therapy," has been employed for centuries, with civilizations like the Greeks and Egyptians using cold baths for therapeutic purposes. Yet, the modern incarnation of whole-body cryotherapy (WBC) originated in Japan during the latter half of the 20th century. Dr. Toshima Yamaguchi, a Japanese doctor, developed the first cryotherapy chamber, primarily for alleviating pain and inflammation.

The Scientific Principles at Play

Cryotherapy operates on a simple yet powerful principle: exposing the body to extreme cold stimulates its natural healing mechanisms. The exposure to these icy temperatures causes vasoconstriction, narrowing blood vessels and reducing blood flow to extremities. This physiological response prompts the release of endorphins, natural painkillers, and simultaneously reduces inflammation. These inherent reactions make cryotherapy a compelling option for various health and wellness objectives.

Applications of Cryotherapy

Pain Management

Cryotherapy's primary application is pain management. Athletes frequently turn to cryotherapy to reduce muscle soreness and inflammation following rigorous workouts. The localized application of cold provides rapid relief, making it a sought-after solution for athletes and individuals dealing with chronic pain conditions.

Skin Rejuvenation

Cryotherapy's benefits extend to the beauty and wellness realm. Cryofacials, involving the application of cold nitrogen gas to the face, claim to enhance skin elasticity, diminish wrinkles, and yield a more youthful appearance. The cold exposure purportedly stimulates collagen production and enhances blood flow to the skin, resulting in a revitalized complexion.

Weight Management

Another emerging cryotherapy application is in the realm of weight management. Some cryotherapy centers offer services that aim to help individuals burn calories and shed pounds through exposure to frigid temperatures. The underlying idea is that the body expends energy to maintain warmth, potentially promoting calorie burn. However, the effectiveness of cryotherapy for weight loss remains a subject of debate among experts.

The Expansion of the Cryotherapy Market

The growth of the cryotherapy market can be attributed to several key factors. Let's explore the core elements contributing to the market's expansion.

Rising Health and Wellness Awareness

A surge in health-consciousness has prompted individuals to seek alternative methods to enhance their well-being. The desire for pain relief, faster recovery, and overall health improvements has driven the growth of cryotherapy centers and services.

Celebrity Endorsements

Celebrity endorsements have played a significant role in promoting cryotherapy. High-profile figures such as Cristiano Ronaldo, LeBron James, and Kim Kardashian have openly shared their positive cryotherapy experiences, bolstering public awareness and interest.

Accessibility and Convenience

Cryotherapy centers are becoming increasingly accessible. The convenience of localized cryotherapy centers, where individuals can receive targeted treatments for specific concerns, has made it easier for people to explore cryotherapy as part of their wellness routine.

Investment in Research and Development

Investments in cryotherapy technology and the introduction of innovative devices have attracted capital to the industry. This influx of funds has facilitated further research and development, enhancing the capabilities and safety of cryotherapy.

Challenges and Concerns

While cryotherapy presents numerous benefits, it is not without its challenges and concerns. It is vital to address these issues for a well-rounded understanding of the industry.

Lack of Regulation

One significant concern in the cryotherapy market is the lack of standardized regulation. The absence of comprehensive guidelines underscores the importance of consumers researching and selecting reputable cryotherapy centers for safety.

Potential Risks

Cryotherapy may not be suitable for everyone and can pose risks, particularly for individuals with certain medical conditions. Consulting a healthcare professional before embarking on cryotherapy is essential, especially if there are underlying health issues.

Conclusion

The surge in the cryotherapy market reflects the growing interest in alternative health and wellness therapies. With its historical foundations, scientific principles, and diverse applications, cryotherapy has evolved into a thriving industry. However, it's crucial for consumers to remain informed and exercise caution when considering cryotherapy treatments.

Maximizing energy efficiency with Structural Insulated Panels (SIPs) is a goal that aligns with sustainable building practices and cost savings. SIPs, with their superior insulation properties, play a crucial role in achieving this objective. In this blog, we will explore how SIPs can be used to maximize energy efficiency in construction.

1. Enhanced Insulation Properties

SIPs are well-known for their exceptional thermal resistance. The core of rigid foam insulation sandwiched between two layers of structural boards, typically oriented strand board (OSB), creates an airtight barrier. This design significantly reduces heat transfer, making buildings with SIPs far more energy-efficient than traditional structures.

2. Reduced Heating and Cooling Costs

One of the most significant advantages of SIPs is the reduction in heating and cooling energy requirements. Due to their high insulation values, buildings constructed with SIPs can maintain comfortable indoor temperatures with minimal energy input. This translates to lower utility bills for homeowners and businesses.

3. Net Zero Energy Buildings (NZEBs)

SIPs are a valuable asset in the creation of Net Zero Energy Buildings (NZEBs). These buildings aim to produce as much energy as they consume. SIPs, with their exceptional insulation and airtight construction, significantly reduce the energy required for heating, cooling, and lighting. When coupled with renewable energy sources like solar panels, SIP-built structures can achieve the goal of NZEBs.

4. Comfort and Indoor Air Quality

Beyond energy savings, SIPs contribute to the overall comfort and well-being of building occupants. Their airtight construction minimizes drafts, resulting in a more consistent and comfortable indoor environment. Additionally, SIPs help maintain superior indoor air quality by preventing moisture infiltration, reducing the risk of mold, allergens, and other indoor pollutants.

5. Sustainability and Environmental Benefits

SIPs are an eco-friendly choice. The materials used in SIPs are typically renewable and sourced from sustainable forests. Additionally, the long-term energy savings achieved with SIPs can offset the environmental impact associated with their production. This sustainability aspect aligns with the growing emphasis on reducing the environmental footprint of construction.

6. Faster Construction Time

SIPs can be prefabricated, which accelerates the construction process. Shorter construction periods result in reduced labor costs and less disturbance to the environment. This efficiency not only saves time and money but also contributes to reduced energy consumption during the construction phase.

7. Resistance to Extreme Weather Conditions

SIPs are known for their structural integrity and ability to withstand extreme weather conditions. This resilience ensures that the building envelope remains intact, preventing energy loss through gaps and leaks, even in harsh climates.

In the ever-evolving world of healthcare, technological advancements have continuously reshaped the landscape of patient care and medical practices. Among these innovations, 3D printing has emerged as a groundbreaking force, revolutionizing the way medical devices are designed, produced, and utilized. This blog will explore the fascinating and dynamic realm of 3D printing in healthcare, focusing on its applications, benefits, and its profound impact on the medical device industry. From customized prosthetics to complex surgical tools, 3D printing is changing the face of healthcare. In this blog, we'll delve into the significant developments and future prospects of 3D printing in the healthcare sector.

The Beginnings of 3D Printing in Healthcare

A Leap Forward in Customization

3D printing, also known as additive manufacturing, has been around since the 1980s, predominantly used in aerospace and automotive industries. However, in recent years, it has rapidly penetrated the healthcare sector. What sets 3D printing apart is its ability to create objects layer by layer, driven by digital designs. This unique approach allows for the production of highly customized medical devices tailored to the precise needs of individual patients.

The Versatility of 3D-Printed Medical Devices

One of the greatest advantages of 3D-printed medical devices is their remarkable versatility. These devices can span from simple anatomical models for surgical planning to intricate, patient-specific implants. Surgeons and healthcare professionals leverage this technology to enhance patient care in numerous ways, from developing prosthetics, orthopedic implants, and dental devices, to patient-specific surgical tools.

The Impact on Patient Care

Personalized Solutions for Patients

Conventional, one-size-fits-all medical devices often fall short in addressing the unique needs of patients. 3D printing allows the creation of bespoke solutions that fit a patient's anatomy perfectly. For instance, a patient in need of a prosthetic limb can now have a device that aligns precisely with their body, resulting in increased comfort and functionality.

Faster Prototyping and Iteration

In the field of medical device development, time is often of the essence. 3D printing facilitates rapid prototyping, enabling manufacturers to create multiple iterations of a device in a short period. This not only accelerates the design process but also ensures the final product is of the highest quality. A significant advantage when time can be a crucial factor in patient care.

Advantages for Healthcare Professionals

Enhanced Surgical Planning

Surgeons can utilize 3D-printed anatomical models to plan complex procedures with enhanced precision. Having an accurate representation of a patient's unique anatomy allows them to identify potential challenges and practice surgical techniques beforehand. The result is safer and more efficient surgeries.

Improved Training Opportunities

Medical students and residents can benefit significantly from 3D-printed models for training purposes. These models provide a hands-on learning experience, allowing students to practice procedures and gain confidence before working on real patients. It's a valuable educational tool that ultimately enhances the skills of future healthcare professionals.

The Economic Aspect

Cost-Effective Production

Traditionally, producing custom medical devices was a costly endeavor. 3D printing has changed this paradigm by reducing production costs. With this technology, complex, patient-specific devices can be manufactured efficiently and economically. This cost-effectiveness translates into more accessible healthcare solutions for patients.

Reducing Medical Waste

The healthcare industry has long been criticized for generating significant amounts of waste. 3D printing can help address this issue by producing medical devices on-demand, minimizing excess inventory and waste. As a result, it is not only environmentally friendly but also contributes to more sustainable healthcare practices.

Challenges and Future Prospects

Regulatory Hurdles

Despite its tremendous potential, 3D printing in healthcare faces regulatory challenges. Ensuring the safety and efficacy of 3D-printed medical devices is of paramount importance. Regulatory bodies, like the FDA, are continually working to establish guidelines and standards to govern their use.

Ongoing Research and Development

The field of 3D printing in healthcare is still evolving, with ongoing research and development efforts aimed at pushing the boundaries of what is possible. We can expect to see more innovations in materials, printing technologies, and applications in the years to come.

Conclusion

Sirolimus is a macrolide compound also known as rapamycin, which is a potent immunosuppressant and shows both antifungal and antineoplastic properties. It works by weakening the immune system, and helps your body to accept the new organ, so in this manner it helps in preventing rejection of any organs after transplant. Sirolimus is also used to coat coronary stents, and prophylaxis of organ transplant rejection in patients receiving renal transplants, and for treating Lymphangioleiomyomatosis (lung disease).

Request a sample copy of this report:- https://www.coherentmarketinsights.com/insight/request-sample/2842

Approvals for generic versions of Rapamune (a branded sirolimus formulation) for preventing organ transplant rejection is expected to drive the global sirolimus market growth. For instance, in January 2019, Novitium Pharma LLC. received the final approval for its abbreviated new drug application (ANDA) from the U.S. FDA to market a generic version of an oral solution of Rapamune 1mg/ml manufactured by PF Prism CV. In October 2014, Dr. Reddys Laboratories Ltd., received the final approval for its abbreviated new drug application (ANDA) from the U.S, FDA to market a generic version of Rapamune tablet dosage (1mg). Thus, approvals of sirolimus products by regulatory authorities to manage (or prevent) organ transplant rejection is expected to drive growth of the global sirolimus market. Factors such as rising incidence of kidney diseases has led to an increase in the number of kidney transplants. Furthermore, increasing prevalence of lifestyle-related disorders, improvement of healthcare infrastructure due to increasing healthcare spending is expected to support global sirolimus market growth over the forecast period. According to the National Kidney Foundation, in 2014, around 17,107 kidney transplants took place in the U.S., among which, 5,537 kidneys were from living donors, and 11,570 kidneys were from deceased donors.

Moreover, rising incidence of Alagille syndrome, Cystinosis, Glomerulonephritis, Nephrotic syndrome, thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), Interstitial nephritis, and others is expected to result in increasing demand for transplants. Major market players are engaged in research and development activities and product launches in order to introduce optimized dosage forms. For instance, in 2014, Rapamune, a formulation developed by Pfizer, lost its exclusivity as an immunosuppressant for kidney transplant rejection management in the U.S. However, in 2015, Rapamune became the first U.S. FDA approved drug for treating Lymphangioleiomyomatosis (LAM) which is a rare progressive lung disease. These factors are expected to support global sirolimus market growth over the forecast period.

North America is expected to dominate the global sirolimus market due to an increasing number of product approvals for preventing organ transplant rejection. For instance, one of the major leading company Pfizer Inc. has carried out various clinical trial studies on sirolimus 1mg/2mg dose for different treatments such as graft rejection, kidney transplant, renal allograft recipients, and renal transplants which has successfully completed phase IV in 2013. Furthermore, growing demand for kidney transplants is expected to propel growth of the global sirolimus market growth over the forecast period. According to the National Kidney Foundation, 2014 in U.S. data, every month approximately 3,000 patients were added to the kidney transplant waiting list, and an estimated 13 people died each day while waiting for a life-saving kidney transplant.

Some of the factors restraining the global sirolimus market growth are the side effects associated with sirolimus such as increased susceptibility to infection, malignancy, hypertriglyceridemia, hypercholesterolemia, angioedema, and proteinuria. Administering sirolimus to patients undergoing liver and lung transplants is generally avoided owing to side effects such as hyperlipidemia and hepatic artery thrombosis.

Some of the major players operating in the global sirolimus market include Pfizer Inc., Actiza, Zydus Cadila Healthcare Ltd., Inc., Greenstone Llc., Biocon, Livzon NNR, and Intas Pharmaceuticals Ltd.

Get the main link:-  https://www.coherentmarketinsights.com/ongoing-insight/sirolimus-market-2842

Contact Us:      

A bladder scanner is a medical device that utilizes ultrasound to noninvasively measure the amount of urine in the bladder, or to determine how much urine remains in the bladder after urination as a way to measure the residual levels. The scanner provides quick and reliable information in the diagnosis and effective treatment of several urological conditions. It also decreases the occurrence of urinary tract infections (UTIs) and prevents unnecessary catheterization. The scanner is used to evaluate urinary retention, bladder volume and post-void residual volume in postoperative patients with decreased urine output and patients with urinary incontinence, urethral stricture, UTIs, enlarged prostate, neurogenic bladder, and other type of lower urinary tract dysfunctions.

Request a sample copy of this report:- https://www.coherentmarketinsights.com/insight/request-sample/2843

Increasing prevalence of urological diseases are expected to drive growth of the global bladder scanner market. Urological diseases are more common in elderly population. Urinary incontinence is common condition among the urinary diseases. Urinary incontinence is the involuntary loss of urine. Therefore, growing prevalence of urological diseases is expected to increase the bladder scanner demand. According to National Institute of Diabetes and Digestive and Kidney Diseases, based upon the national public health survey published in 2018, it is estimated that 1 in 10 U.S. adults suffer from daily urinary incontinence; most of those affected are women.

Increasing number of surgical procedures such as urethral surgery is expected to drive the global bladder scanner market growth during the forecast period. Increasing number of minimally invasive procedures for urological conditions, which is expected to fuel growth of global bladder scanner market.

Furthermore, manufacturers and researchers are developing advanced systems for scanning the bladder and measuring its volume by nurses. For instance, in February 2019, EchoNous, an announced the release of EchoNous Bladder, a highly reliable, non-mechanical bladder scanning tool for nurses. This helps nurses to quickly determine the bladder volume of patients.

Moreover, in January 2015, dBMEDx received 510(k) clearance from the U.S Food and Drug Administration (FDA) to market its novel bladder scanner, the BBS Revolution. This device is easy to use; it has accuracy and speed for the non-invasive measurement of bladder volume.  

However, the development of other diagnostic technologies and procedures hamper growth of global bladder scanner market. Moreover the unfavorable reimbursement policies and negative perception about urodynamic studies is likely to hamper growth of global bladder scanner market.

North America holds dominant position in the global bladder scanner market, owing to the high adoption rate of ultrasound bladder scanner among urologists and urogynecologists and presence of large number of testing centers in the region. Moreover, increase in incidence of urological dysfunction and advancements in urodynamics capital equipment are other factors driving the bladder scanner market growth in the North America. According to the National Institute of diabetes and digestive and kidney Diseases (NIDDK), in 2010, as many 1 in 3 older men lose the urine by accident. Moreover, in November 2017, Verathon Inc. announced the launch of its new portable 3D ultrasound instrument known as BladderScan Prime Plus. BladderScan Prime Plus provides the accuracy with enhanced ‘point and click’ ease of use. 

Asia Pacific is the second largest market in the global bladder scanner market, owing to increase in incidence of urinary incontinence, stress incontinence and lower urinary tract symptoms (LUTS) in the region. Moreover the rise in disposable income of population fuels growth of the market in Asia Pacific.

Some of the key players operating in the global bladder scanner market include Verathon, Vitacon, Meike, Echo-Son, SRS Medical, LABORIE, dBMEDx, MCube Technology, Caresono, Sonostar Technologies, EchoNous.

Get the main link:-  https://www.coherentmarketinsights.com/ongoing-insight/bladder-scanner-market-2843

Contact Us:      

Medical Dynamometers are devices that measure the strength of different muscle groups along with bones and neurons. It is a medical device that is used for measuring patient’s hand strength to evaluate the patient trauma or hand dysfunction as well as to determine how a patient is responding for ongoing treatment and therapy. These devices are utilized for clinical decision making and outcome evaluation of pathologies such as tendon injury of the hand, carpal tunnel syndrome, neuromuscular disorder, and nerve injury. Various types of medical dynamometers are used such as hand dynamometers, wrist dynamometer, pinch dynamometer and inclinometers. These devices are used to test the muscle strength of hand, grip strength, pinch strength, and also measure the range of motion. Medical dynamometer is an alternative to physiotherapy treatment for those suffering from various joint, muscle, and tendon disorders. These devices are efficient in rapid pain management and mobility restoration.    

Request a sample copy of this report:- https://www.coherentmarketinsights.com/insight/request-sample/2844

Increasing prevalence of orthopedic surgeries, increase in arthritic patients, rise in ergonomic health approaches, surge in research and development initiatives, and increase in demand for diagnostic devices drive the global medical dynamometer market growth. According to the National Inpatient Sample, in 2014, there were 370,770 total hip replacements (THR) and 680,150 total knee replacements (TKR) in the U.S. According to American Academy of Orthopedic Surgeons, by 2030, primary THR is projected to grow 171% and primary TKR is projected to grow by up to 189%, for a projected 635,000 and 1.28 million procedures, respectively.

Moreover, rise in prevalence of bone injuries drive growth of the global medical dynamometer market. According to International Osteoporosis Foundation (IOF), 2017, osteoporosis causes over 8.9 million fractures across the world each year, with an osteoporotic fracture every 3 seconds. IOF further states that by 2050, the global incidence of hip fracture in men is projected to increase by 310% and 240% in women. Furthermore, increase in sports injuries also fuel the global medical dynamometer market. For instance, according to the Center for Disease Control and Prevention, high school athletes alone account for 2 million injuries, 50,000 doctor visits, and 30,000 hospitalizations in the U.S. each year.

Moreover, manufacturers and researchers are developing advanced systems for rehabilitation of post stroke patients left with upper-extremity hemiparesis. For instance, in July 2016, Biodex Medical Systems, Inc., a provider of innovative medical devices, announced the availability of upper extremity hemiparetic attachments for its multi joint system computerized robotic dynamometer. Furthermore, in January 2019, ActivBody introduced the Activforce, a digital dynamometer platform designed to increase clinician’s access to precise data, creating a more efficient experience with manual muscle testing.  

However, high costs associated with the medical dynamometer is restraining the market growth.

North America holds dominant position in the global medical dynamometer market, owing to the high occurrence of accidents coupled with early diagnosis of diseases such as arthritis.

Asia Pacific is expected to be the fastest developing region in global medical dynamometer market. Increasing number of population in the region with growing number of fatal accidents is expected to be the major factor driving the market growth in the region. For instance, according to the ministry of Road Transport and Highways, Government of India, the total number of fatal accidents in 2015 were 1,31,726, whereas it grew to 1,36,071 in 2016. 

Some of the key players operating in the global medical dynamometer market include JTECH Medical Industries, Inc., 3B Scientific, KERN and SOHN GmbH, Hausmann Industries, Fabrication Enterprises, Charder Electronic, Marsden Weighing Group, Lafayette Instrument, Biodex Medical Systems, and North Coast Medical.

Get the main link:-  https://www.coherentmarketinsights.com/ongoing-insight/medical-dynamometer-market-2844

Contact Us:      

Wearable patches are known as smart patches or electronic skin. These are thin, small, and flexible in nature, and are used for disease monitoring, drug delivery, and diagnosis. Wearable patches help to maintain health and wellbeing in elderly patients suffering from chronic conditions such as diabetes and others. Presently, the market of wearable technologies is growing, owing to increasing research and development activities for development of wearable patch carried out by key players operating in the market. Wearable patches can be worn or stuck to the skin, or patch’s such as scopolamine patches and transdermal patch are directly attached to the affected body part for disease monitoring. For instance, a nicotine path is a transdermal patch, which releases nicotine into the body, and is used in nicotine replacement therapy (NRT).

Request a sample copy of this report:- https://www.coherentmarketinsights.com/insight/request-sample/2891

The global wearable patch market size is expected to be valued at US$ 318.1 million in 2019, and is expected to exhibit a CAGR of 22.9% over the forecast period (2019-2027).

Increasing prevalence of chronic diseases such as diabetes and atrial fibrillation is resulting in high number of stroke incidents, which is expected to drive growth of the wearable patch market over the forecast period. For instance, according to the International Diabetes Federation report published in November 2019, around 463 million adults between the age group of 20 to 79 years were diagnosed with diabetes across the globe, and it is expected that the total diabetes population will reach around 700 million by 2045 globally.

Moreover, according to the American Heart Association, January 2019, stroke was a leading cause of death in the U.S. with around 2.7 million people in the country living with atrial fibrillation and around 800,000 people encounter stroke, annually, due to blockage in the blood vessel, which supplies blood to the brain. Therefore, increasing prevalence of atrial fibrillation is expected to boost growth of the wearable patch market.

Wearable patches are used for monitoring and diagnosis of chronic diseases. Increasing prevalence of diseases such as atrial fibrillation has led to increase in demand for wearable patches for early diagnosis. This rising demand has led by major players in the market to launch new and technologically advanced wearable patch. For instance, in July 2018, LifeSignals, a solution provider for health and wellbeing, received the U.S. Food and Drugs Administration (FDA) approval for wireless LP1100 Life Signal Patch, a next generation wearable healthcare monitoring device. LP1100 Life Signal Patch is a clinical-grade, two-lead ECG, and heart rate monitoring patch, which has three-day monitoring capacity.

Furthermore, in November 2018, L’Oreal and La Roche-Posay launched ‘My Skin Track UV’, a wearable skin and sun safety sensor to help women and men to track their personalized exposure to UV, pollution, pollen, and humidity.

However, high cost of sensor monitoring patch is expected to hinder growth market growth in emerging economies such as India, Brazil and China. The average price of ECG sensor patch is around US$ 300 to US$ 4,500. Market players, who can address the cost issue and can offer high quality products in emerging economies are expected to enhance their market share in the particular region.

Major players operating in the global wearable patch market include Medtronic Plc, Hill-Rom Holdings, Inc. (Welch Allyn), iRhythm Technologies, Inc., AliveCor, Inc., Vivalnk, Inc., Cardiac Insight Inc., VitalConnect, LifeSignals, Inc., L’oreal Group, Dexcom, Inc., GENTAG, Inc., Abbott Laboratories, and  Koninklijke Philips N.V.

Get the main link:-  https://www.coherentmarketinsights.com/market-insight/wearable-patch-market-2891

Contact Us:      

Chemotherapy chairs are used for multiple purposes such as cancer treatment, autoimmune disease treatment during the infusion process of drugs. There are different type of chairs for patients such as adult chairs, pediatric chairs, bariatric chairs (for obese cancer patients). Increasing donations from the Thunder Bay Regional Health Services Foundation is expected to aid growth of global chemotherapy chairs market. For instance, in November 2013, Lake of the Woods Regional Hospital received an amount of US$ 3,785 to purchase two treatment chairs for the hospital’s chemotherapy clinic, which are designed for patients weighing over 300 pounds. The money is a grant from the Thunder Bay Regional Health Services Foundation, which will allow the hospital to order the special chemotherapy chairs.

Request a sample copy of this report:- https://www.coherentmarketinsights.com/insight/request-sample/2932

The global chemotherapy chair market size is expected to witness significant growth, owing to increasing number of new cancer care centers where chemotherapy or infusion chairs are frequently used. For instance, in September 2018, Tennessee Oncology, New York Cancer & Blood Specialists, and West Cancer Center in partnership announced the launch of OneOncology a community-based cancer care center across the U.S. It is patient-centric, physician-driven, and technology-powered cancer center with a mission to improve the lives of everyone living with cancer. Furthermore, in June 2019, Arizona Blood & Cancer Specialists announced that they will open six new clinics serving patients in Tucson, Green Valley, Nogales and Safford. Together, OneOncology and Arizona Blood & Cancer Specialists will build multidisciplinary, comprehensive cancer centers to provide an exceptional, personalized experience across the continuum of care from prevention and diagnosis, to clinical trials and treatment, through survivorship, palliative, and supportive care.

Moreover, chemotherapy is also used for treatment of blood disorder, plethora of autoimmune diseases and etc. Therefore, the global chemotherapy chairs market is also expected to increase, owing to increasing prevalence autoimmune diseases worldwide. According to the American Autoimmune Related Diseases Association (AARDA) report of 2017, autoimmune diseases affect 5% to 10% of the global population, particularly women, who are two to ten times more likely to suffer from an AD than men. Some of the autoimmune diseases are within the top 10 leading causes of death among women aged 65 years and above.

There are few hospitals already taking pace in starting new cancer units with high investments on their set up which includes chemotherapy equipment like chairs. For instance, in May 2018, Solihull Haematology and Oncology Day Unit project conducted by Solihull Hospital, managed by managed by University Hospitals Birmingham NHS Foundation, opened their new unit on chemotherapy treatment with an investment of US$ 2.5 million. They mentioned the requirement of 31 patient treatment chairs in the three years in which 24 chairs required in the initial stage. These kind of initiations in the treatment of cancers expected to increase the demand of chemotherapy chairs in the near future.

North America is expected to hold a dominant position in the global chemotherapy chairs market during the forecast period, owing to increasing incidences of childhood cancer. For instance, according to the National Cancer Institute (NCI) report of 2018, it is estimated that around 15,590 children and adolescents aged 0 to 19 years were diagnosed with cancer and around 1,780 died of the disease in the U.S. in 2018.

Europe is expected to foresee a rapid growth in the global chemotherapy chairs market. The market in Europe is expected to gain momentum during the forecast period, owing to high presence of key players in the region such as Likamed GmbH, GREINER GmbH, and Bionic Medizintechnik GmbH. These are Germany-based companies, incorporated with advanced technology. Moreover, BMB Medical and Earthlite Medical are also Europe-based companies.

   Key players operating in the global chemotherapy chairs market include BMB Medical, Earthlite Medical, Nanning Passion Medical Equipment, Likamed GmbH, GREINER GmbH, Bionic Medizintechnik GmbH, and Paramount Bed Co. Ltd.

Get the main link:-  https://www.coherentmarketinsights.com/market-insight/chemotherapy-chairs-market-2932

Contact Us: